Database for Clinical and Anamnestic Data in Pulmonary Hypertension
Recruiting · NCT01607502 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medical University of Graz
View the official record on ClinicalTrials.gov →What this trial is about
Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography and cardio pulmonary exercise testing. In the diagnosis process and in the follow up of PH patients biomarkers like NTproBNP are helpful. There are no specific biomarkers for the disease which can make the diagnosis process easier and predict prognosis. The systematic data collection in a data base provides better information about patients in daily routine and clinical studies as well as in the design of new studies.
Who can take part
Inclusion criteria
- patients with pulmonary hypertension
- patients at risk for getting pulmonary hypertension
- patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent.
Exclusion criteria
- patients without written informed consent
Where it is running
1 location listed.
- Medical University of Graz - Graz, Austria